FibroGen Inc (FGEN)
1.24
+0.05
(+4.20%)
USD |
NASDAQ |
May 16, 16:00
1.24
0.00 (0.00%)
After-Hours: 20:00
FibroGen Accounts Receivable (Quarterly): 37.08M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 37.08M |
December 31, 2023 | 12.55M |
September 30, 2023 | 31.69M |
June 30, 2023 | 25.60M |
March 31, 2023 | 17.65M |
December 31, 2022 | 16.30M |
September 30, 2022 | 15.33M |
June 30, 2022 | 33.57M |
March 31, 2022 | 43.88M |
December 31, 2021 | 17.40M |
September 30, 2021 | 35.99M |
June 30, 2021 | 24.27M |
March 31, 2021 | 40.54M |
December 31, 2020 | 41.88M |
September 30, 2020 | 26.25M |
June 30, 2020 | 26.52M |
March 31, 2020 | 58.54M |
December 31, 2019 | 28.46M |
September 30, 2019 | 19.22M |
June 30, 2019 | 6.453M |
March 31, 2019 | 6.023M |
Date | Value |
---|---|
December 31, 2018 | 63.68M |
September 30, 2018 | 23.19M |
June 30, 2018 | 30.19M |
March 31, 2018 | 9.975M |
December 31, 2017 | 8.452M |
September 30, 2017 | 8.628M |
June 30, 2017 | 8.933M |
March 31, 2017 | 7.248M |
December 31, 2016 | 10.45M |
September 30, 2016 | 7.692M |
June 30, 2016 | 18.09M |
March 31, 2016 | 5.937M |
December 31, 2015 | 15.40M |
September 30, 2015 | 7.373M |
June 30, 2015 | 12.18M |
March 31, 2015 | 6.963M |
December 31, 2014 | 13.45M |
September 30, 2014 | 21.42M |
June 30, 2014 | 16.17M |
December 31, 2013 | 17.50M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
6.453M
Minimum
Jun 2019
58.54M
Maximum
Mar 2020
27.96M
Average
26.39M
Median
Accounts Receivable (Quarterly) Benchmarks
Annovis Bio Inc | -- |
Emergent BioSolutions Inc | 194.10M |
Vertex Pharmaceuticals Inc | 1.793B |
Geron Corp | -- |
Nanoviricides Inc | -- |